
Anusha MD
@md_anusha
Wife, Mom, Heme-Onc fellow @KUcancercenter, @ASCOTECAG, #ASCOTrainee Council, MedEd enthusiast, love heme-onc, Tweets are my own.
ID: 1239339207832809479
15-03-2020 23:54:38
724 Tweet
539 Followers
1,1K Following

Low dose IO! Tata Memorial Hospital group presented by the outstanding Vanita Noronha, MBBS MD DM providing more data to support the use of low dose especially in more resource constrained environments but continues to challenge the doses we use


Catching up on #ASCO25 - terrific discussion by Tian Zhang, MD, MHS UTSW Simmons Cancer Center on abstracts from #SamerSrourMD MD Anderson Cancer Center, Toni Choueiri, MD Dana-Farber News, Robert Motzer MD Memorial Sloan Kettering Cancer Center & Vivek Narayan Penn Medicine - Abramson Cancer Center. Varied topics all eloquently addressed! Thanks for citing the



"The key to success in academia is to surround yourself with people that believe in your cause, are not afraid to fight for equality, & are their true selves." Dr Narjust Florez, MD, FASCO on finding peer mentors, life long friends, & creating community #ASCO25 👉medscape.com/viewarticle/97…


😇 Honored to serve as discussant for #ASCO25 oral upper GI abstracts. A powerhouse session with science featured simultaneously in 2 NEJM papers, 1 The Lancet , and 1 Journal of Clinical Oncology —field-leading science shaping our GI oncology practice ✨. UPMC Hillman Cancer Center


Recognizing Top Oncologists, Top Women Oncologists, and Rising Stars from ASCO 2025 at Times Square! Dr Amol Akhade | Paolo Tarantino | Aakash Desai, MD, MPH, FASCO | Stephen V Liu, MD | Hidehito HORINOUCHI | Toni Choueiri, MD | Yakup Ergün | Neeraj Agarwal, MD, FASCO | Andrea Necchi | Sharlene Gill, MD, MPH, MBA, FASCO | Aya Mohamed | MSc, MD 🎗 |

Congratulations to Toni Choueiri, MD on being the recipient of a Doctorate Honoris Causa from The Lebanese University recognizing his outstanding achievements in Oncology.


Congratulations Toni Choueiri, MD! So well-deserved and a true testament to your huge impact on our field 👏👏

Now Anup Kasi MD MPH presenting Updates in Hepatobiliary and pancreatic Cancer @ Hematology/Oncoloogy Review KU Cancer Center #MedEd #MedTwitter #سرطان_الدم #المايلوما OncoAlert


Now pannel discussion Anusha MD Anup Kasi MD MPH Nausheen Ahmed MD Abdulraheem Yacoub and Dr. Bhatt KU Cancer Center #MedEd #MedTwitter OncoAlert USMIRC News #سرطان_الدم #المايلوما


Now pannel discussion Anusha MD Li Haoran, MD, PhD Dr. Weijing Sun and Dr. Christine Bestivina KU Cancer Center #MedEd #MedTwitter OncoAlert USMIRC News #سرطان_الدم #المايلوما


Now Dr. Christine Bestvina from University of Chicago presenting Novel Clinical Advances in lung cancer cancer @ Hematology/Oncoloogy Review KU Cancer Center USMIRC News OncoAlert #MedEd #MedTwitter #سرطان_الدم #المايلوما wow Taraltamab (The BiTe for small cell lung cancer!!)


Al-Ola A Abdallah MD (USMIRC) KU Cancer Center OncoAlert USMIRC News Dr. Abdallah on podium. Myeloma update.


🚨 STELLAR-303 makes history! First-ever Ph3 trial to show OS benefit of IO in MSS CRC 🎯 Years of grit & belief led us here 🥹 Endless thanks to Exelixis for the trust & Dr. Hecht for leading this global win with me! 🎉 UPMC Hillman Cancer Center ir.exelixis.com/news-releases/…

Honored to moderate the Post-ASCO 2025 Updates at KU Cancer Center. Great discussions, impactful science, and inspiring colleagues Prakash Neupane Anup kashi Al-Ola A Abdallah MD (USMIRC) Nausheen Ahmed MD Abdulraheem Yacoub


As the waves 🌊 settle after #ASCO25 we Dana-Farber Lank Center for Genitourinary Oncology take a deeper dive 🤿 into the most impactful data! Join Toni Choueiri, MD Bradley McGregor Atish Choudhury, MD PhD as we discuss what we learned & where we’re going next! Prostate 🔗 youtu.be/heLQLuWjlzM Bladder 🔗



Starting Now: Radioimmunotherapy and Adjuvant Trials Moderated by: Suresh S. Ramalingam, MD, FASCO Winship Cancer Institute of Emory University #DAVALung


Does the time of day affect ICI efficacy? Dr. Sandip Patel Sandip Patel MD FASCO UC San Diego Health reviewed studies showing AM > PM outcomes for anti–PD-(L)1 in NSCLC, while noting practical limits and the need for further data. #DAVALung
